Nymox Pharmaceutical Corporation (NYMXF)
USD 0.14
(-8.36%)
USD 0.14
(-8.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 627 Thousand USD | -61.42% |
| 2022 | 1.62 Million USD | -20.03% |
| 2021 | 2.03 Million USD | -58.8% |
| 2020 | 4.93 Million USD | -18.85% |
| 2019 | 6.07 Million USD | -32.04% |
| 2018 | 8.94 Million USD | 427.05% |
| 2017 | 1.69 Million USD | -17.5% |
| 2016 | 2.05 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 627 Thousand USD | -61.42% |
| 2023 Q4 | 627 Thousand USD | -6.28% |
| 2023 Q3 | 669 Thousand USD | 146.86% |
| 2023 Q2 | 271 Thousand USD | -52.87% |
| 2023 Q1 | 575 Thousand USD | -64.62% |
| 2022 Q1 | 3.72 Million USD | 83.42% |
| 2022 Q4 | 1.62 Million USD | -56.43% |
| 2022 Q3 | 3.73 Million USD | -26.33% |
| 2022 Q2 | 5.06 Million USD | 35.85% |
| 2021 Q4 | 2.03 Million USD | -54.23% |
| 2021 Q3 | 4.44 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -27042.857% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 67.981% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 94.059% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -13.562% |
| Rebus Holdings, Inc. | 5000.00 USD | -12440.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.518% |
| Qrons Inc. | 420.00 USD | -149185.714% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | 18.639% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 97.756% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -30.474% |
| Skye Bioscience, Inc. | 11.94 Million USD | 94.749% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 98.386% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 91.316% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -721.175% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.415% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 56.216% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -766.441% |
| Mesoblast Limited | 667.9 Million USD | 99.906% |
| Marizyme, Inc. | 22.01 Million USD | 97.152% |
| Genus plc | 1.02 Billion USD | 99.939% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 53.841% |
| Pharming Group N.V. | 462.85 Million USD | 99.865% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 81.075% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -25.641% |
| ContraFect Corporation | 20.67 Million USD | 96.968% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -60.618% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -64.06% |
| IMV Inc. | 31.33 Million USD | 97.999% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 84.877% |
| MultiCell Technologies, Inc. | 126.22 USD | -496651.703% |
| ONE Bio Corp. | 70.08 Million USD | 99.105% |
| Accustem Sciences Inc. | 939.68 Thousand USD | 33.276% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.512% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -45.235% |
| Q BioMed Inc. | 3.51 Million USD | 82.165% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 98.218% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -139.975% |
| Biomind Labs Inc. | 73.81 Thousand USD | -749.375% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.86% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 56.724% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 97.911% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 77.17% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | 8.798% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 75.914% |
| GB Sciences, Inc. | 103.44 Thousand USD | -506.137% |
| Alpha Cognition Inc. | 2.45 Million USD | 74.431% |
| HST Global, Inc. | 1526.00 USD | -40987.811% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 36.536% |
| Halberd Corporation | 10.13 Thousand USD | -6088.925% |
| Enzolytics Inc. | 361.7 Million USD | 99.827% |
| Agentix Corp. | 261.39 Thousand USD | -139.87% |
| Resverlogix Corp. | 8.11 Million USD | 92.274% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 66.611% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.986% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 98.686% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | 1.979% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -2652.294% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 92.994% |
| AVAX Technologies, Inc. | 7.37 Million USD | 91.501% |
| Zenith Capital Corp. | 7410.00 USD | -8361.538% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.981% |
| Ember Therapeutics, Inc. | 184.00 USD | -340660.87% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -94.838% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -139.895% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | 32.433% |
| Kadimastem Ltd | 2.3 Million USD | 72.787% |
| Helix BioMedix, Inc. | 3.02 Million USD | 79.273% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 98.81% |
| BioStem Technologies, Inc. | 14.56 Million USD | 95.694% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -998.189% |
| LadRx Corporation | 2.3 Million USD | 72.832% |
| Cell Source, Inc. | 195.17 Thousand USD | -221.257% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -77.31% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -77.31% |
| NovAccess Global Inc. | 62.24 Thousand USD | -907.261% |
| Affymax, Inc. | 7.44 Million USD | 91.576% |
| Itoco Inc. | 1.4 Million USD | 55.217% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -555.467% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -491.509% |
| Mobile Lads Corp. | 52.00 USD | -1205669.231% |
| CytoDyn Inc. | 11.13 Million USD | 94.37% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -338.547% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -3406.711% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -62.658% |
| SYBLEU INC | 330.46 Thousand USD | -89.731% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -53.143% |
| International Stem Cell Corporation | 5.39 Million USD | 88.367% |
| Bioxytran, Inc. | 137.63 Thousand USD | -355.543% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 95.821% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 96.218% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -693.671% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | 27.487% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 91.659% |
| Neutra Corp. | 2851.00 USD | -21892.283% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 98.065% |
| PureTech Health plc | 693.97 Million USD | 99.91% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 92.232% |
| IXICO plc | 15.84 Million USD | 96.043% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 92.429% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.393% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Cellectis S.A. | 333.99 Million USD | 99.812% |